Actavis Antibiotic Drug Gets FDA Nod to Treat cIAI and cUTI

December 7, 2014 2:47 PM

3 0

An FDA advisory panel voted to recommend a new drug for treating abdominal and urinary tract infections. The antibiotic is developed by Actavis and AstraZeneca as treatment for serious conditions caused by drug-resistant bacteria.(Photo : Dominique Godbout)

An FDA advisory panel voted to recommend a new drug for treating abdominal and urinary tract infections. The antibiotic is developed by Actavis and AstraZeneca as treatment for serious conditions caused by drug-resistant bacteria.

Read more

To category page

Loading...